Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on April 13, 2006

"Rinat is a pioneer in developing protein-based therapeutics and we see tremendous potential in its research to develop new medicines, notably for the treatment of Alzheimer's disease. Combining Rinat's potential product portfolio with Pfizer's capabilities is a further step in our strategy to enhance Pfizer's internal research and development efforts with high-potential, externally sourced product candidates and technologies."
Some of the compounds in Rinat's pipeline are RN624, a nerve growth factor inhibitor for treatment of acute and chronic pain (currently entering Phase II clinical trials) and RN1219, a humanized monoclonal antibody for the potential treatment of Alzheimer's disease.
Permalink: Pfizer Acquires Rinat Neuroscience Corp.
Tags:
alzheimer
acquisition
biotech
rinat
pfizer
neuroscience+corp
rinat+neuroscience
pfizer+acquires
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20024
Mr Wong
Vote for Pfizer Acquires Rinat Neuroscience Corp.:
|
Rating: 8.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







